BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14690416)

  • 1. Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4.
    Torimoto N; Ishii I; Hata M; Nakamura H; Imada H; Ariyoshi N; Ohmori S; Igarashi T; Kitada M
    Biochemistry; 2003 Dec; 42(51):15068-77. PubMed ID: 14690416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes.
    Nakamura H; Nakasa H; Ishii I; Ariyoshi N; Igarashi T; Ohmori S; Kitada M
    Drug Metab Dispos; 2002 May; 30(5):534-40. PubMed ID: 11950784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids.
    Nakamura H; Torimoto N; Ishii I; Ariyoshi N; Nakasa H; Ohmori S; Kitada M
    Drug Metab Dispos; 2003 Apr; 31(4):432-8. PubMed ID: 12642469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical calculation of triazolam hydroxylation and endogenous steroid inhibition in the active site of CYP3A4.
    Torimoto N; Ishii I; Hata M; Kobayashi Y; Nakamura H; Ariyoshi N; Kitada M
    Biochim Biophys Acta; 2007 Feb; 1774(2):223-32. PubMed ID: 17204458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
    Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
    Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.
    Denisov IG; Grinkova YV; Baylon JL; Tajkhorshid E; Sligar SG
    Biochemistry; 2015 Apr; 54(13):2227-39. PubMed ID: 25777547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epoxidation mechanism of carbamazepine by CYP3A4.
    Hata M; Tanaka Y; Kyoda N; Osakabe T; Yuki H; Ishii I; Kitada M; Neya S; Hoshino T
    Bioorg Med Chem; 2008 May; 16(9):5134-48. PubMed ID: 18372180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.
    Denisov IG; Grinkova YV; Nandigrami P; Shekhar M; Tajkhorshid E; Sligar SG
    Biochemistry; 2019 Mar; 58(10):1411-1422. PubMed ID: 30785734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
    Kang P; Liao M; Wester MR; Leeder JS; Pearce RE; Correia MA
    Drug Metab Dispos; 2008 Mar; 36(3):490-9. PubMed ID: 18096676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
    Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
    Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives.
    Shou M; Mei Q; Ettore MW; Dai R; Baillie TA; Rushmore TH
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):845-53. PubMed ID: 10359672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
    Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
    Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
    Badawi AF; Cavalieri EL; Rogan EG
    Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic model for the metabolic interaction of two substrates at the active site of cytochrome P450 3A4.
    Shou M; Dai R; Cui D; Korzekwa KR; Baillie TA; Rushmore TH
    J Biol Chem; 2001 Jan; 276(3):2256-62. PubMed ID: 11054425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites.
    Korzekwa KR; Krishnamachary N; Shou M; Ogai A; Parise RA; Rettie AE; Gonzalez FJ; Tracy TS
    Biochemistry; 1998 Mar; 37(12):4137-47. PubMed ID: 9521735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics.
    Harlow GR; Halpert JR
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6636-41. PubMed ID: 9618464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
    Sevrioukova IF
    J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mechanism-Based Model for the Prediction of the Metabolic Sites of Steroids Mediated by Cytochrome P450 3A4.
    Dai ZR; Ai CZ; Ge GB; He YQ; Wu JJ; Wang JY; Man HZ; Jia Y; Yang L
    Int J Mol Sci; 2015 Jun; 16(7):14677-94. PubMed ID: 26133240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent.
    Wang RW; Newton DJ; Liu N; Atkins WM; Lu AY
    Drug Metab Dispos; 2000 Mar; 28(3):360-6. PubMed ID: 10681383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site.
    Dabrowski MJ; Schrag ML; Wienkers LC; Atkins WM
    J Am Chem Soc; 2002 Oct; 124(40):11866-7. PubMed ID: 12358527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.